Afuco™ Anti-Human PIVKA-II ADCC Therapeutic Antibody, ADCC Enhanced

Anti-PIVKA-II ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. It relates to antibodies or binding proteins which bind to PIVKA II, and may be used, for example, in the diagnosis, treatment and prevention of hepatocellular carcinoma (HCC), liver cancer and related conditions.
Supplier Creative Biolabs
Product # AFC-738CL
Pricing Inquiry
Host Human
Target PIVKA-II
Species Reactivity Human
Type ADCC enhanced antibody
Storage 4°C or -20°C, avoid repeated freezing and thawing.
Feedback